首页> 外文期刊>Dermatologic surgery >Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa.
【24h】

Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa.

机译:皮肤和粘膜的默克尔细胞癌:报告12例皮肤病例,其中2例来自鼻粘膜。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Merkel cell carcinoma (MCC) is an uncommon skin tumor that most frequently arises on sun-exposed facial sites. It rarely occurs on mucous membranes of the head region. The primary MCC is usually treated by wide excision followed by radiation to the primary site and regional lymph nodes. Using traditional surgery the local recurrence rate ranges from 20 to 50%. In our clinic, Mohs surgery is used to excise the primary MCC completely, followed by radiation. Here we present our treatment experiences and outcomes. OBJECTIVE: To document our experience of MCC treated by Mohs surgery. We present our series of 12 cases of MCC, 2 cases of which arose from mucosal sites of the nasal cavity. METHODS: We reviewed 12 cases of MCC from the Mohs clinic database. We also reviewed the literature for cutaneous and mucosal MCC. RESULTS: There were 12 cases of MCC: 10 cutaneous and 2 mucous. The site distribution of cutaneous MCC was eight on the head, one on the neck, and one on the groin. Of these, nine were treated by Mohs excision. Two patients developed local recurrence following Mohs treatment. The local recurrence rate was 22% (2 of 9). The sites of mucosal MCC were the nasal septum and nasopharynx. One case had a history of previous radiation and developed an MCC 40 years later. This case also demonstrated epidermotropic spread of Merkel cells to the overlying mucous epithelium. This patient required extensive intranasal and cranial surgery to remove the tumor. Both patients with mucosal MCCs died of their disease. The overall mucocutaneous survival of MCC at 1 year was 80% and at 2 years was 50%. CONCLUSION: In our series, local control of the primary MCC was achieved in 70% of patients (7 of 10) using combined Mohs excision and radiation. Two recurrences had primary tumors larger than 3.5 cm in diameter, while the other case was nonresectable by Mohs surgery. Tumor size appeared to determine the degree of local control. When the postoperative Mohs defect was less than 3.0 cm in diameter, local and regional control appeared to be more favorable. When the primary facial MCC is relatively small, removal by Mohs surgery followed by radiation was effective, therapeutic, and less disfiguring. Mucosal MCC is rare and may occur as a long-term sequelae after radiation therapy to the skin.
机译:背景:默克尔细胞癌(MCC)是一种罕见的皮肤肿瘤,最常见于暴露在阳光下的面部部位。它很少发生在头部的粘膜上。原发性MCC通常通过广泛切除,然后放射至原发部位和区域淋巴结进行治疗。使用传统手术,局部复发率范围为20%至50%。在我们的诊所中,莫氏手术用于完全切除原发性MCC,然后进行放射治疗。在这里,我们介绍我们的治疗经验和结果。目的:记录我们接受莫氏手术治疗的MCC的经验。我们介绍了我们的一系列12例MCC,其中2例来自鼻腔粘膜部位。方法:我们从莫氏诊所数据库中回顾了12例MCC病例。我们还回顾了皮肤和粘膜MCC的文献。结果:MCC共有12例,皮肤10例,粘液2例。皮肤MCC的部位分布在头部为八个,在颈部为一个,在腹股沟为一个。其中,有9例接受了Mohs切除术治疗。 Mohs治疗后两名患者出现局部复发。局部复发率为22%(2/9)。粘膜MCC的部位是鼻中隔和鼻咽。一个病例有先前的放射史,并在40年后发展为MCC。该病例还证明了默克尔细胞在表皮上向上层粘液上皮扩散。该患者需要进行广泛的鼻内和颅骨手术以去除肿瘤。两名患有粘膜MCC的患者均死于疾病。 1年时MCC的整体粘膜皮肤生存率为80%,而2年时为50%。结论:在我们的系列研究中,结合使用Mohs切除和放射治疗,在70%的患者(每10名患者中有7名)实现了对原发性MCC的局部控制。两次复发的原发肿瘤直径大于3.5厘米,而另一例无法通过Mohs手术切除。肿瘤大小似乎决定了局部控制的程度。当术后Mohs缺损直径小于3.0 cm时,局部和区域控制似乎更为有利。当主要的面部MCC相对较小时,通过Mohs手术切除再进行放射线切除是有效的,治疗性的并且具有较小的容貌。粘膜MCC很少见,可能在对放射线治疗后作为长期后遗症发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号